Copyright
©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 108253
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.108253
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.108253
Table 1 Types of progressive familial intrahepatic cholestasis with corresponding gene mutation, proteins affected, and key features
PFIC type | Gene | Protein affected | Pathophysiology | Key features | GGT | Extrahepatic symptoms |
PFIC1 | ATP8B1 | FIC1 (flippase) | Canalicular membrane instability; impaired bile salt resistance | Cholestasis, diarrhea, growth failure, deafness | Normal | Diarrhea, short stature, deafness, pancreatitis |
PFIC2 | ABCB11 | BSEP | Impaired bile salt excretion | Severe cholestasis, early liver failure, Increased risk of Hepatocellular carcinoma risk | Normal | None typically |
PFIC3 | ABCB4 | MDR3 | Deficient phosphatidylcholine secretion → toxic bile | Later onset, biliary fibrosis, cirrhosis | High | None typically |
PFIC4 | TJP2 | ZO-2 | Tight junction disruption → bile leaks into liver tissue | Pruritus, portal hypertension, hearing loss | Low | Hearing loss, respiratory issues |
PFIC5 | NR1H4 | FXR | Decreased bile acid regulation and BSEP expression | Neonatal cholestasis, bleeding, ↑ International Normalization Ratio, ↑ Alpha Feto Protein | Normal | Coagulopathy (vitamin K-resistant) |
PFIC6 | SLC51A | OSTα | Impaired bile acid reabsorption from intestine | Diarrhea, jaundice, hepatosplenomegaly | High | Severe diarrhea, bleeding tendency |
PFIC7 | USP53 | USP53 | Tight junction dysfunction | Episodic cholestasis, vitamin deficiency, deafness | Normal | Hearing loss, developmental delay, cardiomyopathy |
PFIC8 | KIF12 | KIF12 | Disrupted intracellular transport, MRP2 mislocalization | Variable: Cholestasis to cirrhosis | High | None typically |
PFIC9 | ZFYVE19 | ZFYVE19 | Ciliopathy affecting bile duct cilia and transporter localization | Cholestasis, hepatospleno-megaly, Gastrointestinal bleeding | High | Ciliary dysfunction; systemic involvement |
PFIC10 | MYO5B | Myosin 5B | Defective transporter trafficking (e.g., BSEP) | Cholestasis ± microvillous inclusion disease | Normal/Low | Diarrhea, pruritus |
PFIC11 | SEMA7A | Semaphorin-7A | Abnormal transporter placement (via PKC pathway) | Jaundice, ↑ ALT/AST, no pruritus | Normal | None reported |
PFIC12 | VPS33B | VPS33B | Defective intracellular trafficking | Neonatal cholestasis, pruritus | Normal | Mild renal/skeletal issues |
PFIC13 | PSKH1 | PSKH1 | Hepatorenal ciliopathy | Cholestasis + kidney disease | Variable | Renal disease, anemia, diaphragmatic hernia |
- Citation: Mkarem LE, Batika MAH, Bitar R. New hope in treating progressive familial intrahepatic cholestasis in children. World J Hepatol 2025; 17(7): 108253
- URL: https://www.wjgnet.com/1948-5182/full/v17/i7/108253.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i7.108253